BI Asset Management Fondsmaeglerselskab’s Charles River Laboratories CRL Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,629	Closed	-$1.04M	–	917
2024 Q4	$1.04M	Buy	5,629 +2,975	+112%	+$573K	0.01%	509
2024 Q3	$523K	Buy	2,654 +1,890	+247%	+$393K	0.01%	469
2024 Q2	$158K	Sell	764 -848	-53%	-$192K	﹤0.01%	578
2024 Q1	$437K	Sell	1,612 -604	-27%	-$144K	0.01%	557
2023 Q4	$524K	Buy	2,216 +1,340	+153%	+$264K	0.01%	512
2023 Q3	$172K	Hold	876	–	–	﹤0.01%	632
2023 Q2	$184K	Hold	876	–	–	﹤0.01%	620
2023 Q1	$177K	Buy	876 +505	+136%	+$114K	﹤0.01%	606
2022 Q4	$81K	Buy	+371	New	+$81K	﹤0.01%	621

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's CRL Position: Q1 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 5,629 shares — an estimated $1.04M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in CRL in Q4 2022 and held it in 9 quarters. The position peaked at $1.04M in Q4 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

BI Asset Management Fondsmaeglerselskab reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
BI Asset Management Fondsmaeglerselskab sold 5,629 Charles River Laboratories shares in Q1 2025, an estimated $1.04M.
BI Asset Management Fondsmaeglerselskab first reported a position in Charles River Laboratories in Q4 2022 and held it in 9 quarters.
BI Asset Management Fondsmaeglerselskab's Charles River Laboratories position peaked at $1.04M in Q4 2024.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2025, filed 14 May 2025.